Butylphthalide - CSPC Ouyi Pharmaceutical

Drug Profile

Butylphthalide - CSPC Ouyi Pharmaceutical

Alternative Names: Butylphthalide and sodium chloride injection; Dl-3-butylphthalide; En Bi Pu; L-butylphthalide; NBP injection; NBP soft capsule

Latest Information Update: 26 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CSPC Ouyi Pharmaceutical
  • Class Benzofurans; Ketones; Phytotherapies; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Stroke

Most Recent Events

  • 14 Sep 2016 CSPC-NBP Pharmaceutical plans a phase II trial for Stroke in USA (PO, Capsule) (NCT02905565)
  • 09 May 2016 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top